Ascentage Pharma Group International (NASDAQ:AAPG – Get Free Report) shares gapped up prior to trading on Thursday . The stock had previously closed at $18.37, but opened at $19.96. Ascentage Pharma Group International shares last traded at $20.05, with a volume of 23,192 shares traded.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. initiated coverage on shares of Ascentage Pharma Group International in a research report on Thursday. They set an “overweight” rating on the stock.
View Our Latest Report on Ascentage Pharma Group International
Ascentage Pharma Group International Stock Up 7.2 %
Ascentage Pharma Group International Company Profile
Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Further Reading
- Five stocks we like better than Ascentage Pharma Group International
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Find and Profitably Trade Stocks at 52-Week Lows
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- What is the Hang Seng index?
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Ascentage Pharma Group International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascentage Pharma Group International and related companies with MarketBeat.com's FREE daily email newsletter.
